Gaiane M Rauch

24PUBLICATIONS
145CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 22, 2026
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.

|Dec 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

Beatriz E Adrada, Mary S Guirguis, Lei Huo

|Nov 20, 2025
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer.

Mary S Guirguis, Beatriz E Adrada, Clinton Yam

|Oct 30, 2025
SAR Disease-focused Panel: Restaging Rectal Cancer MRI Synoptic Report-User Guide with Imaging Review.

Shannon P Sheedy, Supreeta Arya, Akshay D Baheti

|Sep 23, 2025
Molecular Breast Imaging and Digital Breast Tomosynthesis for Dense Breast Screening: The Density MATTERS Trial.

Carrie B Hruska, Katie N Hunt, Nicholas B Larson

|Aug 26, 2025
MRI-Based Mathematical Modeling to Predict the Response of I-SPY 2 Patients with Breast Cancer to Neoadjuvant Therapy.

Reshmi J S Patel, Chengyue Wu, Casey E Stowers

Pageof 4

Frequent Collaborators

7 joint publications

Beatriz E Adrada

6 joint publications

Debu Tripathy

6 joint publications

Jason White

4 joint publications

Jennifer Litton